Predictions
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.62
13.09.22
13.09.22
-
13.09.23
13.09.23
-37.10%
17.09.22
17.09.22
Could be very worthwhile Investment >20% year
Leap Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.96
13.09.22
13.09.22
-
13.09.23
13.09.23
-17.60%
18.09.22
18.09.22
Could be worthwhile Investment >10% per year
Mercadolibre Inc
Start price
Target price
Perf. (%)
€990.90
12.09.22
12.09.22
€1,010.0
12.09.23
12.09.23
-8.14%
20.09.22
20.09.22
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Very low/no dividend yield expected
Mercadolibre Inc
Start price
Target price
Perf. (%)
€990.90
12.09.22
12.09.22
€1,010.0
12.09.23
12.09.23
-8.14%
20.09.22
20.09.22
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Very low/no dividend yield expected
Catana Group
Start price
Target price
Perf. (%)
€6.24
10.09.22
10.09.22
-
10.09.23
10.09.23
9.29%
11.09.23
11.09.23
Could be worthwhile Investment >10% per year
T-Mobile US Inc.
Start price
Target price
Perf. (%)
€146.00
10.09.22
10.09.22
-
10.09.23
10.09.23
4.25%
29.10.22
29.10.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Valuable balance sheet
ROE higher than 10% per year
T-Mobile US Inc.
Start price
Target price
Perf. (%)
€146.00
10.09.22
10.09.22
-
10.09.23
10.09.23
4.25%
29.10.22
29.10.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Valuable balance sheet
ROE higher than 10% per year
T-Mobile US Inc.
Start price
Target price
Perf. (%)
€146.00
10.09.22
10.09.22
-
10.09.23
10.09.23
4.25%
29.10.22
29.10.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Valuable balance sheet
ROE higher than 10% per year
Procter & Gamble Co.
Start price
Target price
Perf. (%)
€139.20
10.09.22
10.09.22
€145.00
10.09.23
10.09.23
1.29%
30.11.22
30.11.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Good rating
Procter & Gamble Co.
Start price
Target price
Perf. (%)
€139.20
10.09.22
10.09.22
€145.00
10.09.23
10.09.23
1.29%
30.11.22
30.11.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Good rating
ShiftPixy Inc.
Start price
Target price
Perf. (%)
€31.30
10.09.22
10.09.22
€4.00
10.09.23
10.09.23
-37.16%
17.09.22
17.09.22
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
Very low/no dividend yield expected
very negative Cash Flow expected
ShiftPixy Inc.
Start price
Target price
Perf. (%)
€31.30
10.09.22
10.09.22
€11.00
10.09.23
10.09.23
-37.16%
17.09.22
17.09.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
